AKT1 and thromboangiitis obliterans: Treatment with 50 ng/ml IGF-1 induced phosphorylation of IGF-1Rβ at Tyr1135 by 2.49 fold and Akt at Thr308 by 2.54 fold and Ser473 by 2.34 fold in OFs from TAO patients (Fig 4).